ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

Glucose Meter utilizes iOS operating system.

Print | 
Email |  Comment   Share  
August 21, 2014 - Designed to connect to headphone jack on iPhoneŽ, iPodŽ touch, or iPadŽ, GmateŽ SMART Blood Glucose Monitoring System uses GmateŽ SMART app to deliver blood glucose test results, without use of adapter or Bluetooth device. Together, app and meter provide goal setting, graphing, and ability to email or text blood glucose test results directly to healthcare provider.

Philosys Launches GMATE® SMART Meter and App - Improving Diabetes Health


Philosys
304 Park Avenue South, Suite 218
New York, NY, 10010
USA



Press release date: August 15, 2014

GmateŽ SMART connects with iPhoneŽ, iPadŽ and iPodŽ touch to deliver accurate and fast blood glucose results

NEW YORK, -- Philosys announces it has received U.S. Food and Drug Administration (FDA) 510K approval for the highly anticipated GmateŽ SMART Blood Glucose Monitoring System. The GmateŽ SMART meter is the size of a quarter and connects to the headphone jack on the iPhone, iPod touch or iPad, while using the free GmateŽ SMART app to deliver blood glucose test results, without the use of an adapter or Bluetooth device. The patent pending technology uses the operating system of the iOS device. For many people in the US, their iPhone, iPad or iPod touch has become an integral part of organizing their daily lives. The GmateŽ SMART app and meter integrates diabetes management directly to an iOS device while providing the following features: goal setting, graphing, and the ability to email or text blood glucose test results directly to your healthcare provider. This platform launches diabetes management into the future of better care, for a better you.

According to Center for Technology Innovation at Brookings, chronic diseases such as diabetes are costly and taxing on the current system. The use of mobile technologies that monitor patient symptoms and provide real-time treatment options have the potential to control costs, reduce errors, and improve the overall patient experience.(1) Mike Tickle, Senior VP of Philosys' Sales adds that, "This is an exciting time for Philosys as we continue our efforts to be a technology leader for the diabetes mobile monitoring arena. The GmateŽ SMART will give our customers TeleHealth capabilities with the accuracy and quality they deserve at a cost effective price."

FDA 510K approval is an important milestone for Philosys in offering this technology to people with diabetes in the US, as well as globally. Philosys continues to move forward in their commitment to providing innovative health solutions to people with diabetes around the world.

About Philosys
Philosys is a manufacturing company that specializes in medical, diagnostics and analytical instruments. Philosys' philosophy is to develop cost-effective design and manufacturing solutions that satisfy our customer's vision. Visit www.gmate.com.

1. Governance Studies The Brookings - Institution Improving Health Care through Mobile Medical Devices and Sensors

CONTACT: Billie Orlando, Philosys, 855-464-6283, http://www.gmate.com
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



 See related product stories
More .....
 See more product news in:
Sensors, Monitors and Transducers
Test and Measuring Instruments
| Featured Manufacturing Jobs
 Tools for you
Watch Company 
Company web site
More news from this company
E-mail this story to a friend
Save Story
Search for suppliers of
Blood Chemistry Analyzers
Blood & Blood Pressure Testers
Join the forum discussion at:
Tools of the Trade




Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2014 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy



Error close

Please enter a valid email address